Role of Tyrosine Nitrosylation in Stress-Induced Major Depressive Disorder: Mechanisms and Implications.
antidepressants
catalase
ceramide
hippocampus
major depressive disorder
neuroinflammation
neuroplasticity
peroxidases
phosphatidic acid
tyrosine nitrosylation
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
27 Sep 2023
27 Sep 2023
Historique:
received:
29
08
2023
revised:
25
09
2023
accepted:
25
09
2023
medline:
1
11
2023
pubmed:
14
10
2023
entrez:
14
10
2023
Statut:
epublish
Résumé
Major depressive disorder (MDD) has a lifetime prevalence of approximately 10% and is one of the most common diseases worldwide. Although many pathogenetic mechanisms of MDD have been proposed, molecular details and a unifying hypothesis of the pathogenesis of MDD remain to be defined. Here, we investigated whether tyrosine nitrosylation, which is caused by reaction of the C-atom 3 of the tyrosine phenol ring with peroxynitrate (ONOO
Identifiants
pubmed: 37834072
pii: ijms241914626
doi: 10.3390/ijms241914626
pmc: PMC10572173
pii:
doi:
Substances chimiques
Glucocorticoids
0
Tyrosine
42HK56048U
Antidepressive Agents
0
Fluoxetine
01K63SUP8D
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Deutsche Forschungsgemeinschaft
ID : Deutsche Forschungsgemeinsschaft DFG Gu 335/29-3 and Gu 335/42-1
Références
Nat Commun. 2022 Jan 10;13(1):164
pubmed: 35013188
J Neurosci. 2000 Dec 15;20(24):9104-10
pubmed: 11124987
Acta Psychiatr Scand. 1997 Mar;95(3):212-21
pubmed: 9111854
Mol Psychiatry. 2005 Apr;10(4):345-52
pubmed: 15655562
J Neurochem. 2022 Nov;163(4):357-369
pubmed: 36227646
Metabolism. 2019 Jun;95:65-76
pubmed: 30954559
Science. 2010 Aug 20;329(5994):959-64
pubmed: 20724638
Nat Neurosci. 2017 Dec;20(12):1752-1760
pubmed: 29184215
Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4003-8
pubmed: 15020765
Nature. 1985 Feb 7-13;313(6002):479-81
pubmed: 2982106
J Comp Physiol B. 2004 Nov;174(8):593-9
pubmed: 15449090
J Neurosci. 2009 Jan 7;29(1):14-22
pubmed: 19129380
Br Med Bull. 2001;57:61-79
pubmed: 11719924
Recent Pat CNS Drug Discov. 2006 Jan;1(1):29-41
pubmed: 18221189
Biochim Biophys Acta. 1975 Apr 14;387(1):176-87
pubmed: 164939
Nature. 2008 Oct 16;455(7215):894-902
pubmed: 18923511
Psychosom Med. 2009 Feb;71(2):171-86
pubmed: 19188531
Psychiatry Res. 1993 Oct;49(1):11-27
pubmed: 7511248
J Biol Chem. 2022 Aug;298(8):102185
pubmed: 35753355
N Engl J Med. 2008 Jan 3;358(1):55-68
pubmed: 18172175
Neuropsychopharmacology. 2011 Jul;36(8):1754-68
pubmed: 21508931
Pharmacol Ther. 2004 Apr;102(1):47-60
pubmed: 15056498
J Neuropsychiatry Clin Neurosci. 2011 Spring;23(2):215-8
pubmed: 21677254
Cell Mol Neurobiol. 2022 Nov;42(8):2571-2591
pubmed: 34637015
Clin Chim Acta. 2021 Jul;518:110-115
pubmed: 33775701
Science. 2019 Apr 12;364(6436):
pubmed: 30975859
Br J Pharmacol. 1990 Oct;101(2):325-8
pubmed: 1701676
Mol Psychiatry. 2018 Dec;23(12):2324-2346
pubmed: 30038230
PLoS Med. 2014 Nov 11;11(11):e1001755
pubmed: 25386878
Behav Brain Res. 2020 Jan 27;378:112245
pubmed: 31539575
Biol Psychiatry. 2010 Mar 1;67(5):446-57
pubmed: 20015486
Biol Psychiatry. 2000 Feb 15;47(4):351-4
pubmed: 10686270
Exp Mol Med. 2018 Apr 6;50(4):1-10
pubmed: 29622768
Psychopharmacology (Berl). 1985;85(4):387-404
pubmed: 2410942
J Mol Med (Berl). 2022 Oct;100(10):1493-1508
pubmed: 36045177
Mol Psychiatry. 2022 Sep;27(9):3822-3832
pubmed: 35618888
Circ Res. 2019 Feb 15;124(4):564-574
pubmed: 30582458
Science. 2003 Aug 8;301(5634):805-9
pubmed: 12907793
Front Psychiatry. 2021 Sep 16;12:690130
pubmed: 34603096
Psychopharmacology (Berl). 2023 Sep;240(9):1825-1840
pubmed: 37507462